CNBC

IDEV's Pivotal SUPERB Trial Demonstrates SUPERA® Stent Significantly Exceeds VIVA Criteria for One-Year Patency in Femoropopliteal Artery Disease

LAS VEGAS and WEBSTER, Texas, Oct. 10, 2012 /PRNewswire/ -- IDEV Technologies, Inc. (IDEV) today announced positive clinical outcomes for its SUPERB pivotal clinical trial of its SUPERA® Peripheral ...
FierceBiotech

Late-Breaking Data Presented at Vascular InterVentional Advances (VIVA) 2012 Conference in Las Vegas

LAS VEGAS and WEBSTER, Texas, Oct. 10, 2012 /PRNewswire/ -- IDEV Technologies, Inc. (IDEV) today announced positive clinical outcomes for its SUPERB pivotal clinical trial of its SUPERA® Peripheral ...
TCTMD

FDA Approves Medtronic's Complete 'SE' Vascular Stent for Use in Superficial Femoral and Proximal Popliteal (Leg) Arteries

New Indications for Self-Expanding Device Address Broad Area of Peripheral Artery Disease MINNEAPOLIS --Expanding its role in the treatment of peripheral artery disease in the United States, Medtronic ...
TCTMD

STROLL at 3 Years: Nitinol Stent Demonstrates Sustained Patency, QoL in SFA Patients

Patients with superficial femoral/popliteal lesions experience significant and sustained improvements out to 3 years with a self-expanding nitinol stent. Updated data from the STROLL trial, presented ...
Healio

Paradigm to treat superficial femoral artery, popliteal disease with high calcification remains unclear

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — In a session focused on lower-extremity intervention in superficial femoral artery and popliteal ...
Business Wire

PQ Bypass Receives FDA “Breakthrough Device Designation” for the World’s First Fully Percutaneous Femoral-Popliteal Bypass Device

MILPITAS, Calif.--(BUSINESS WIRE)--PQ Bypass Inc, a medical device pioneer bringing new advancements to the treatment of advanced peripheral artery disease (PAD), announced today that they received ...
Business Wire

PQ Bypass Announces First Patient Treated in Landmark DETOUR II Trial Evaluating New Treatment Approach for Clogged Leg Arteries

Enabled by PQ Bypass’ patented DETOUR™ System, the DETOUR procedure creates an endovascular bypass, using proprietary stent grafts, that originates in the SFA, travels through the femoral vein, then ...
Medscape

Durable Patency With Superficial Femoral Artery Stenting

November 21, 2011 (New York, New York) — Three-year follow-up of the RESILIENT trial has shown that the LifeStent vascular stent (Bard Peripheral Vascular) leads to durable benefits and clinical ...
Healio

Bypass yielded higher reintervention rates than stenting in PAD

Please provide your email address to receive an email when new articles are posted on . Femoral-popliteal bypass was associated with a significantly higher reintervention rate than stenting in a ...
PR Newswire

Long Lesion Study Demonstrates SUPERA(R) Stent Efficacy in SFA and Popliteal Arteries

NOORDWIJKERHOUT, Netherlands and WEBSTER, Texas, May 17, 2011 /PRNewswire/ -- IDEV Technologies announced today that data from a long lesion study of 182 patients with significantly diseased ...
HUB

Study: Minimally invasive stents better for peripheral artery disease

New Johns Hopkins research suggests that people who undergo minimally invasive placement of stents to open clogged leg arteries are significantly less likely than those who have conventional bypass ...